Cadent Therapeutics is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of neurological diseases.
Business Model:
Revenue: $3M
Employees: 11-50
Cadent Therapeutics was acquired by
Novartis.
The acquisition happend on 2020-12-17.
Details of the transaction were not public
Address: 60 Hamilton Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Cadent Therapeutics is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of neurological diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2012 | Series A | 2 | $5.4M |
Access BridgeGap Ventures Slater Technology Fund Access BridgeGap Ventures |
6/2010 | Seed Round | 1 | $250k |
Slater Technology Fund |
11/2018 | Series B | 4 | $40M |
Atlas Venture Cowen Healthcare Investments Novartis Institutes for Biomedical Research Qiming Venture Partners Atlas Venture Cowen Healthcare Investments Novartis Institutes for Biomedical Research Qiming Venture Partners |
6/2013 | Series A | 2 | $6M |
Atlas Venture Clal Biotechnology Industries Atlas Venture Clal Biotechnology Industries |
4/2020 | Series B | 6 | $15M |
Access Industries Atlas Venture Clal Biotechnology Industries Cowen Healthcare Investments Novartis Institutes for Biomedical Research Qiming Venture Partners Access Industries Atlas Venture Clal Biotechnology Industries Cowen Healthcare Investments Novartis Institutes for Biomedical Research Qiming Venture Partners |
---|
Announced Date | Name | Price |
---|---|---|
3/2017 | Ataxion |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|